Criblage pharmacologique de 44 molécules pour des pathologies humaines impliquant des défauts mitochondriaux à l’aide du modèle levure Saccharomyces cerevisiae

Summarise with VIRAT
Authors: de Abreu, Romain, Marc
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Mitochondrial diseases are rare and severe pathologies, often linked to genetic anomalies disrupting energy production and cellular balance. They preferentially affect tissues with high energy demand and currently lack curative treatment. In this context, the yeast Saccharomyces cerevisiae represents a relevant model due to the conservation of mitochondrial functions with human cells and the possibility of creating mutant strains mimicking certain pathological defects. This thesis is based on the screening of forty-four molecules, mainly natural polyphenols derived from grapevine, to evaluate their capacity to restore altered respiratory functions. The analyses combined spot tests, growth curves, and measurements of cellular respiration. The results confirmed a respiratory deficit in the mutant yeasts, which was absent in the wild-type strains. None of the tested molecules showed a corrective effect, while a control compound from another pharmacological screening allowed for partial restoration. These data highlight the interest of the yeast model for studying mitochondrial diseases, while revealing its limitations for the rapid identification of therapeutic candidates. They underscore the need to continue the development of innovative experimental and pharmacological strategies to treat and understand these still orphan diseases.

Fields of Study & Subjects

Mitochondrial Function and Pathology Metabolism and Genetic Disorders Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
HAL
Publication date
20 January 2026
Language
FR
Document type
Thesis